US2009124539A1PendingUtilityA1

Methods of treating infection

Individually held — no corporate assignee on recordPriority: Feb 26, 2007Filed: Sep 26, 2008Published: May 14, 2009
Est. expiryFeb 26, 2027(~0.6 yrs left)· nominal 20-yr term from priority
A61P 31/02A61P 31/04G01N 33/56916A61K 38/15A61P 17/00G01N 33/56944G01N 2800/44G01N 33/56938
35
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to methods of inhibiting the proliferation of bacteria for either ex vivo or in vivo use. The invention also relates to methods of treating a patient infected with an antibiotic resistant bacteria by administering a pharmaceutical composition comprising an Empedopeptin; methods of sanitizing surfaces and instruments; and methods of assaying bacteria for Empedopeptin resistance.

Claims

exact text as granted — not AI-modified
1 . A method of inhibiting bacterial proliferation comprising:
 providing a pharmaceutical composition comprising Empedopeptin or a pharmaceutically acceptable salt thereof,   wherein the bacteria comprises at least one Gram positive strain, and the Gram positive strain is resistant to glycopeptides, aminoglycosides, oxazolidinones, penicillins, macrolides, rifamycins, polypeptides, lipopeptides, chloramphenicol, or any combination thereof.   
     
     
         2 . The method of  claim 1 , wherein the Gram positive strain further comprises  Enterococcus faecalis, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes , or any combination thereof. 
     
     
         3 . The method of  claim 2 , wherein the Gram positive strain is further resistant to at least one of linezolid, oxacillin, vancomycin, daptomycin, erythromycin, methicillin, gentamicin, chloramphenicol, fusidic acid, rifampin, or combinations thereof. 
     
     
         4 . The method of  claim 1 , further comprising providing a second pharmaceutical composition, wherein the second pharmaceutical composition comprises a second antibiotic agent. 
     
     
         5 . An isolated nucleotide sequence comprising SEQ ID NO 1. 
     
     
         6 . An isolated protein sequence comprising SEQ ID NO 2. 
     
     
         7 . An isolated nucleotide sequence comprising SEQ ID NO 3. 
     
     
         8 . An isolated protein sequence comprising SEQ ID NO 4. 
     
     
         9 . An isolated nucleotide sequence comprising SEQ ID NO 5. 
     
     
         10 . An isolated protein sequence comprising SEQ ID NO 6. 
     
     
         11 . An isolated nucleotide sequence comprising SEQ ID NO 7 
     
     
         12 . An isolated protein sequence comprising SEQ ID NO 8.

Join the waitlist — get patent alerts

Track US2009124539A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.